Mylan to invest $1 billion in India on capex in 6 yearsCurrently Mylan has 21 facilities and 15,000 employees working in India.
29 Sep, 2019, 12.47 PM IST
USFDA okays Mylan, Biocon's biosimilar of cancer drug HerceptinOgivri is the first USFDA approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the...
02 Dec, 2017, 01.40 PM IST
Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.
07 Jan, 2016, 10.13 PM IST
Mylan launches hepatitis-C Sovaldi tablets in IndiaSovaldi is sold by Mylan's dedicated sales force as part of its Hepato Care segment.
04 May, 2015, 02.51 PM IST
Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...
28 Apr, 2015, 03.25 PM IST
Mylan Pharmaceuticals launches generic hepatitis C drug MyHep in IndiaUS-based company's Indian arm Mylan NV has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the country, i...
24 Apr, 2015, 03.45 PM IST
US drugmaker Mylan to acquire Famy Care for $750 MillionMylan will pay $750 million to buy the women’s health business of Mumbai-based Famy Care and expand its presence in the market for women’s ...
03 Feb, 2015, 05.32 AM IST
Mylan may buy contraceptive co Famy Care for Rs 3,000 croreMylan is said to have pipped private equity bids from Bain Capital and Advent to move closer to a deal. Hong Kong-based AIF Capital holds 1...
21 Jan, 2015, 01.33 PM IST
Mylan-Abbott deal gets CCI green signalThe CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...
24 Nov, 2014, 07.23 PM IST
Biocon, Mylan challenge ban on using Roche dataBangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court’s interim order which barred them from using Roche’s...
17 Feb, 2014, 05.16 AM IST
Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.
03 Feb, 2014, 08.41 PM IST
Biocon gets DCGI nod to market biosimilar trastuzumab in IndiaBiocon today said it has received approval from the Indian drug regulator to market its biosimilar trastuzumab developed jointly with Mylan.
27 Nov, 2013, 02.30 AM IST
Biocon gets DCGI nod to market biosimilar trastuzumab in IndiaBiocon said it has received approval to market its biosimilar trastuzumab developed jointly with Mylan for treating breast cancer.
26 Nov, 2013, 05.11 PM IST
CCI gives green signal to Mylan-Unichem dealIt observed that the proposed acquisition by Mylan was with the intent to export products to be manufactured at the said facility.
11 Jun, 2013, 08.20 PM IST
- 'Deal is first step towards globalisation'
Matrix Labs’ CEO Rajiv Malik, who came on board July last year, appears to have his task cut out.
29 Aug, 2006, 03.05 AM IST
- Mylan to span out to Europe, Africa
The $1.2-bn US-based Mylan Labs may just have captured value across the chain with the Matrix deal.
29 Aug, 2006, 02.52 AM IST
- US pharma major Mylan buys Matrix Labs
The generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.
29 Aug, 2006, 01.58 AM IST